Neat1 alleviates ischemic injury in skeletal muscles
Authors:
- Kyungmin KimKKKyungmin Kim
- Tao YuTYTao Yu
- Hyejin MunHMHyejin Mun
- Dong Gun OhDODong Gun Oh
- Sangyoon LeeSLSangyoon Lee
- Mirae KimMKMirae Kim
- Jibeen KimJKJibeen Kim
- Yuseon KangYKYuseon Kang
- Joshua LiJLJoshua Li
- Young C. JangYJYoung C. Jang
- Je-Hyun YoonJYJe-Hyun Yoon
- Laura HansenLHLaura Hansen
Preprint
Abstract
Peripheral artery disease (PAD) has historically been regarded as an age-related vascular disorder; however, recent attention has shifted toward the myopathic components of the disease. Conventional interventions, such as revascularization, have had limited success in reversing muscle pathology or preventing adverse outcomes like amputation. Hypoxia-inducible factors (HIFs) are key regulators of cellular responses to ischemia, including the promotion of angiogenesis and glycolysis. While pharmacological stabilization of HIF proteins represents a promising therapeutic strategy, its efficacy is diminished in aged muscles due to their intrinsically low basal HIF expression. We hypothesized that long noncoding RNAs (lncRNAs) might enhance the hypoxic response in aged muscle through post-transcriptional regulation of HIF expression. Our study identified a long noncoding RNA Neat1, as a critical mediator of the hypoxia-induced stress response, including upregulation of Hif1α. In a murine hindlimb ischemia model, Neat1 knockout mice exhibited extensive necrosis following femoral artery ligation, whereas Neat1 overexpression conferred protection against ischemic injury. Mechanistically, we found that Neat1 regulates the stability of Hif1a mRNA, as Hif1a transcript levels were significantly reduced in Neat1-deficient muscle cells. Importantly, aged muscles displayed a blunted hypoxic response due to diminished Hif1a expression—an effect that was reversed through Neat1 overexpression, resulting in improved resistance to ischemic damage. In summary, our findings highlight Neat1 as a novel regulator of muscle adaptation to hypoxia in aging. Enhancing Neat1 expression may represent a promising therapeutic strategy for improving ischemic outcomes in patients with peripheral artery disease.Keywords
This publication has 51 references indexed in Scilit:
- Long noncoding RNAs as versatile molecular regulators of cellular stress response and homeostasisHuman Genetics, 2023
- NEAT1 is essential for metabolic changes that promote breast cancer growth and metastasisCell Metabolism, 2021
- LncRNA NEAT1 contributes to the acquisition of a tumor like-phenotype induced by PM 2.5 in lung bronchial epithelial cells via HIF-1α activationEnvironmental Science and Pollution Research, 2021
- NEAT1 and paraspeckles in neurodegenerative diseases: A missing lnc found?Non-coding RNA Research, 2018
- Paraspeckles: Where Long Noncoding RNA Meets Phase SeparationTrends in Biochemical Sciences, 2018
- miRNAs regulate the HIF switch during hypoxia: a novel therapeutic targetAngiogenesis, 2018
- The long non-coding RNA Neat1 is an important mediator of the therapeutic effect of bexarotene on traumatic brain injury in miceBrain, Behavior, and Immunity, 2017
- Therapeutic angiogenesis for revascularization in peripheral artery diseaseGene, 2013
- Up-regulation of glyceraldehyde-3-phosphate dehydrogenase gene expression by HIF-1 activity depending on Sp1 in hypoxic breast cancer cellsArchives of Biochemistry and Biophysics, 2011
- An Architectural Role for a Nuclear Noncoding RNA: NEAT1 RNA Is Essential for the Structure of ParaspecklesMolecular Cell, 2009